209 related articles for article (PubMed ID: 38170627)
1. Advances in Nanoplatforms for Immunotherapy Applications Targeting the Tumor Microenvironment.
Zhang N; Zhou J; Li S; Cai W; Ru B; Hu J; Liu W; Liu X; Tong X; Zheng X
Mol Pharm; 2024 Feb; 21(2):410-426. PubMed ID: 38170627
[TBL] [Abstract][Full Text] [Related]
2. Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.
Xu Y; Xiong J; Sun X; Gao H
Acta Pharm Sin B; 2022 Dec; 12(12):4327-4347. PubMed ID: 36561994
[TBL] [Abstract][Full Text] [Related]
3. Remodeling tumor microenvironment with nanomedicines.
Martin JD; Miyazaki T; Cabral H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Nov; 13(6):e1730. PubMed ID: 34124849
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles mediated tumor microenvironment modulation: current advances and applications.
Raju GSR; Pavitra E; Varaprasad GL; Bandaru SS; Nagaraju GP; Farran B; Huh YS; Han YK
J Nanobiotechnology; 2022 Jun; 20(1):274. PubMed ID: 35701781
[TBL] [Abstract][Full Text] [Related]
5. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy.
Huang Y; Fan H; Ti H
Asian J Pharm Sci; 2024 Apr; 19(2):100902. PubMed ID: 38595331
[TBL] [Abstract][Full Text] [Related]
8. Engineering metal-phenolic networks for enhancing cancer therapy by tumor microenvironment modulation.
Xie L; Li J; Wang L; Dai Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(3):e1864. PubMed ID: 36333962
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy.
Yang R; Chen L; Wang Y; Zhang L; Zheng X; Yang Y; Zhu Y
Front Immunol; 2023; 14():1237361. PubMed ID: 37575228
[TBL] [Abstract][Full Text] [Related]
10. The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy.
Wo YJ; Gan ASP; Lim X; Tay ISY; Lim S; Lim JCT; Yeong JPS
Cells; 2019 Dec; 9(1):. PubMed ID: 31861847
[TBL] [Abstract][Full Text] [Related]
11. Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy.
Dai Y; Li X; Xue Y; Chen K; Jiao G; Zhu L; Li M; Fan Q; Dai Y; Zhao Q; Shen Q
Acta Biomater; 2023 Aug; 166():496-511. PubMed ID: 37230439
[TBL] [Abstract][Full Text] [Related]
12. Polysaccharide-Based Stimulus-Responsive Nanomedicines for Combination Cancer Immunotherapy.
Li Q; Liu X; Yan C; Zhao B; Zhao Y; Yang L; Shi M; Yu H; Li X; Luo K
Small; 2023 Jun; 19(23):e2206211. PubMed ID: 36890780
[TBL] [Abstract][Full Text] [Related]
13. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
[TBL] [Abstract][Full Text] [Related]
14. Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy.
Phuengkham H; Ren L; Shin IW; Lim YT
Adv Mater; 2019 Aug; 31(34):e1803322. PubMed ID: 30773696
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications.
Wu P; Han J; Gong Y; Liu C; Yu H; Xie N
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297426
[TBL] [Abstract][Full Text] [Related]
16. Design strategies for enhancing antitumor efficacy through tumor microenvironment exploitation using albumin-based nanosystems: A review.
Zhang C; Yang K; Yang G
Int J Biol Macromol; 2024 Feb; 258(Pt 2):129070. PubMed ID: 38163506
[TBL] [Abstract][Full Text] [Related]
17. Smart Nanoplatforms Responding to the Tumor Microenvironment for Precise Drug Delivery in Cancer Therapy.
Wang Y; Deng T; Liu X; Fang X; Mo Y; Xie N; Nie G; Zhang B; Fan X
Int J Nanomedicine; 2024; 19():6253-6277. PubMed ID: 38911497
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
[TBL] [Abstract][Full Text] [Related]
20. Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy.
Peng S; Xiao F; Chen M; Gao H
Adv Sci (Weinh); 2022 Jan; 9(1):e2103836. PubMed ID: 34796689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
